跳至主要内容
临床试验/NCT05628974
NCT05628974招募中不适用

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
1
主要终点
To collect blood samples

研究概览

简要总结

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

详细描述

Our past studies have discovered novel platelet activation pathways that may be targets of therapeutic development. We have also defined an important role for a shift in platelet phenotype in vascular disease. Our studies use both in vivo animal models and validation using human platelets from isolated blood. Platelets from healthy individuals may be compared to patients with vascular diseases in the IRB approved protocol "Vascular Lab Resource" (IRB #19-1451) study which is actively recruiting patients at the Cleveland Clinic Main Campus and studies patients with vascular diseases.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults aged 18 to 65 years old
  • Healthy Male & Female voluntary participants

排除标准

  • Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
  • Individuals with hematopoetic diseases

结局指标

主要结局

To collect blood samples

时间窗: 10 years

To establish a biorepository for normal healthy cohort of subjects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Cameron, MD, PhD

Principal Investigator

The Cleveland Clinic

研究点 (1)

Loading locations...

相似试验